Policy Dissemination Strategies to Improve the Use of Research Evidence in Medicaid Benefits for Opioid Use Disorder Treatment
Principal Investigator(s): Erika Crable, Ph.D.
More than one-third of Americans living with an opioid use disorder are publicly insured by state Medicaid or Children’s Health Insurance Plan (CHIP), but many of these state programs fail to provide sufficient access to lifesaving medications for opioid use disorder (MOUD). Research is critically needed to understand how policymakers overseeing Medicaid/CHIP benefit arrays solicit, receive, and use evidence to define their benefit and utilization management policies for MOUD.
This study will advance policy dissemination science methods to:
- Develop and administer a national survey to Medicaid/CHIP agency and MCO policymakers to identify determinants, mechanisms, and intermediaries that influence their evidence use behaviors.
- Empirically identify and describe distinct subgroups of Medicaid/CHIP agencies and MCOs based on their evidence use behaviors when designing MOUD benefits.
- Design and pilot test the acceptability, appropriateness and feasibility of dissemination strategies, tailored to each latent class, for promoting policymakers’ evidence-based decision-making regarding MOUD benefits.
Funding Information: NIDA, K01, 1K01DA056838-01
Study time period: 2022 - 2027
Policy Implementation Research on Earmarked Taxes for Mental Health Services
Principal Investigator(s): Jonathan Purtle, DrPH New York University, Nicole Stadnick, Ph.D., MPH UC San Diego
The goal of this study is to generate knowledge about how to enhance the ability of earmarked taxes for mental health to increase the reach of evidence-based practices that improve population mental health.
Funding Information: NIMH, R21, MH125261
Study time period: 2020 - 2023
Share, Trust, Organize, Partner: The COVID-19 California Alliance (STOP COVID-19 CA)
Principal Investigator(s): Nicole Stadnick, Ph.D., MPH UC San Diego, Borsika Rabin, Ph.D. UC San Diego
Other Collaborator(s): The Global Action Research Center
This is a California community engagement collaborative aimed at co-creating and evaluating community-driven strategies to increase participation of underserved communities in COVID-19 therapeutic trials.
Funding Information: NIMHD/NHLBI, OTA
Study time period: 2020 - 2024